期刊文献+

Tei指数评价卡维地洛治疗慢性心衰效果研究 被引量:1

The effects of Carvedilol in treating chronic heart failure evaluated by Tei index
下载PDF
导出
摘要 目的:用Tei指数及其他心功能指标评价卡维地洛治疗慢性心衰的效果。方法:63例慢性心衰患者(NYHAⅡ~Ⅲ级)随机分为2组,一组为常规治疗组,用常规抗心衰的方法治疗;另一组为卡维地洛治疗组,在常规治疗方法的基础上加用卡维地洛。所有的病人至少随访6个月,用超声心动图分别检查左室射血分数(LVEF)、Tei指数、左室舒张末期内径(LVIDd)、室间隔舒张末期厚度(IVSd)、左室后壁舒张末期厚度(LVPWd)以及左室的等容收缩期(ICT)、等容舒张期(IRT)、射血时间(ET)。结果:治疗后常规治疗组和卡维地洛治疗组的LVIDd、ICT、IRT和Tei指数均较治疗前显著减低,IVSd、LVPWd、LVEF和ET均显著增加。治疗6个月后,卡维地洛治疗组的LVEF和ET显著高于常规治疗组(P<0.05,P<0.01),卡维地洛治疗组的Tei指数和ICT显著低于常规治疗组(P<0.01,P<0.05)。结论:在常规治疗方法的基础上加用卡维地洛治疗慢性心衰效果好于仅用常规的方法治疗。Tei指数较LVEF和NYHA分级法评价心功能更为敏感。 Objective: To evaluate the effect of Carvedilol on the cardiac function in patients with chronic heart failure (CHF) using Tel index and other cardiac function index. Methods: Sixty-three cases of CHF(NYHA Ⅱ-Ⅲ) were divided randomly into two groups: one group received regular treatment, while the other group was treated with Carvedilol on the basis of regular treatment. All the patients were followed up for at least six months. Left ventricular ejection fraction(LVEF), Tel index, left ventricular internal diameter at end-diastole(LVIDd), interventricular septal thickness at end-diastole (IVSd), left ventricular posterior wall thickness at end-diastole(LVPWd), and isovolumic contraction time(ICT), isovolumic relaxation time (IRT), ejection time (ET) of left ventricle were measured by echocardiography. Results: Compared with pre-treatment, LVIDd, ICT, IRT and Tel index were significantly decreased and IVSd, LVPWd, LVEF, ET were significantly increased after treatment in both regular treatment group and Carvedilol treatment group. After treatment of six months, LVEF and ET in Carvedilol treatment group were significantly higher than those in regular treatment group (P〈0.05,P〈0.01), Tei index, and ICT in Carvedilol treatment group were significantly lower than those in regular treatment group (P〈0.01, P〈0.05). Conclusions: Carvedilol treatment together with regular treatment is more effective than regular treatment only in improving cardiac function of CHF patients and Tei index is more sensitive than LVEF and NYHA classification in evaluating cardiac function.
出处 《中国临床医学影像杂志》 CAS 北大核心 2008年第10期691-693,共3页 Journal of China Clinic Medical Imaging
关键词 心力衰竭 充血性 超声心动描记术 多普勒 彩色 Heart failure, congestive Echocardiography, Doppler, color
  • 相关文献

参考文献6

  • 1Doughty RN, White HD. Carvedilol: use in chronic heart failure [J]. Expert Rev Cardiovasc Ther, 2007, 5(1): 21-31.
  • 2陈瑾,胡大一,张麟,刘秀兰,吴雅峰,李静.卡维地洛对心脏β_1、β_2和α_1受体自身抗体及心功能的影响[J].中华心血管病杂志,2005,33(6):498-501. 被引量:69
  • 3Bruch C, Schmermund A, Marin D, et al. Tei-index in patients with mild-to-moderate congestive heart failure [J]. Eur Heart J, 2000, 21(22): 1822-1824.
  • 4Zhang H, Otsuji Y, Matsukida K, et al. Noninvasive differentiation of normal from pseudonormal restrictive mitral flow using Tei-index combining systolic and diastolic function [J]. Circ J, 2002, 66(9): 831-836.
  • 5Metra M, Nodari S, Parrinello G, et at. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance[J]. Am Heart J, 2003, 145(2): 292-299.
  • 6汪一波,叶淮松.卡维地洛对扩张型心肌病患者心脏重构及心功能影响的观察[J].心脑血管病防治,2005,5(3):35-37. 被引量:5

二级参考文献17

  • 1Wallukat G, Fu ML, Maggnusson Y, et al. Agonistic effects of anti-peptide autibodies and autoantibodies directed against adrenergic and cholinergic rcceptor:absence of desensitization. Blood Pressure, 1996,5(Suppl 3):31-36.
  • 2Podlowski S, Luther HP, Morwinski R, et al. Agonistic anti-β1- adrenergic rcceptor autoantibodies from cardiomyopathy patients reduce the β1- adrenergic rcceptor expression in neonatal rat cardiomyocytes. Circulation,1998,98:2470-2476.
  • 3Luther HP, Homuth V, Wallukat G, et al. α1-adrenergic receptor antibodies in patients with primary hypertension. Hypertension,1997,29:678-682.
  • 4Nakajima T, Ma J, Zida H, et al. Inhibitory effects of carvedilol on calcium channels in vascular smooth muscle cell. Jpn Heart J, 2003,44:963-978.
  • 5Yao A, Kohmoto O, Oyama T, et al. Characteristic effects of alpha1-beta1,2-adrenergic blocking agent, carvedilol, on [Ca2+] I in ventricular myocytes compared with those of timolol and atenolol. Circ J,2003,67:83-90.
  • 6Liu X, Callaerts VZ, Evans KL,et al. Chronic infusion of beta-adrenoceptor antagonist and inverse agonists decrease elevated protein kinase a activity in transgenic mice with cardiac-specific overexpression of human beta2-adrenoceptor. J Cardiovasc Pharmacol, 2002,40:448-455.
  • 7Macfden Rj. Role of the circulating and tissue-based renin-angiotensin system in the development of heart failure:implication for therapy. Cardiology, 1993,83:38-48.
  • 8Constant J. A review of why and how we may use beta-blockers in congestive heart failure. Chest, 1998,113:800-808.
  • 9Wagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet, 1993,342:1441-1446.
  • 10Di Lenarda A, De Maria R, Gavazzi A, et al. Long-term survival effect of metoprolol in dilated cardiomyopathy. The SPIC(Italian Multicentre Cardiomyopathy Study) Group. Heart, 1998, 79:337-344.

共引文献72

同被引文献8

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部